Related Experiment Video
Updated: Jun 19, 2026
08:13
Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)
Published on: January 7, 2018
Metabonomics in diabetes research
Johan H Faber1, Daniel Malmodin, Henrik Toft
1Novo Nordisk A/S, Novo Nordisk Park, Måløv, Denmark.
Journal of Diabetes Science and Technology
|November 4, 2009
Summary
Metabonomics analyzes metabolic responses to understand diseases like diabetes. This approach uses advanced techniques to identify potential biomarkers for early diagnosis and risk assessment.
Area of Science:
- Metabolomics and systems biology.
- Application of analytical chemistry and bioinformatics in biological research.
Background:
- Metabonomics, the quantitative analysis of metabolic profiles, offers insights into disease mechanisms, drug toxicity, and gene function.
- Biological samples like urine and plasma are analyzed using techniques such as NMR spectroscopy and mass spectrometry.
- Multivariate data analysis, including pattern recognition, is crucial for interpreting complex metabolic data.
Purpose of the Study:
- To review current metabonomics technologies and their applications in diabetes research.
- To outline the objectives of the metabonomics component within the EU's Molecular Phenotyping to Accelerate Genomic Epidemiology project.
- To highlight the potential of metabonomics for early diabetes diagnosis and risk identification.
Main Methods:
- Utilizes advanced analytical techniques like proton nuclear magnetic resonance spectroscopy (NMR) and mass spectrometry (MS).
- Employs online separation methods such as high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC), and gas chromatography (GC).
- Integrates multivariate data analysis and pattern recognition for metabolic profile interpretation.
Main Results:
- Metabonomics has shown significant promise in diabetes research, with applications in animal models and emerging clinical studies.
- The review covers existing technologies and reported studies relevant to diabetes.
- Future directions focus on identifying biomarkers for early diabetes detection and risk stratification.
Conclusions:
- Metabonomics is a powerful tool for understanding complex biological systems and disease processes.
- Its application in diabetes research holds potential for improved diagnostics and personalized medicine.
- The integration of advanced analytical techniques and data analysis is key to unlocking the full potential of metabonomics.
Related Concept Videos
01:36Carbohydrate Metabolism
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...